Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • CommuniquĂ© 53 Cover Image

Geoff Thorne joins FH as Chief Technology Officer to drive innovation for clients

September 7, 2022 | Pharma, healthcare, medical technology 

The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to meet our clients’ evolving needs.

- PMLiVE

Geoff Thorne has joined Fishawack Health (FH) as our new Chief Technology Officer. He will focus on refining our technology and strategy offerings to solve complex challenges for our biopharmaceutical, medical technology, and wellness clients.

“The depth and breadth of our technology product offerings continue to grow, especially in analytics and data-driven marketing, where we are making great strides to develop innovative approaches in customer-targeting for our clients,” said Gail Flockhart, Chief Commercial Officer and President of Marketing. “With roots in client delivery, passion for innovation, and a belief in cross-functional team collaboration, Geoff is well-positioned to drive our technology strategy forward to serve the needs of our clients. He will also ensure the expansion of our best-in-class products and services for clients across the pre-commercial and commercial lifecycle of therapies and services.”

In his previous role at Digitas Health, Geoff served as the lead technical executive, building the company’s technology capabilities and scaling client engagements. He also led a team of over 70 technologists focused on client delivery while creating a collaborative culture.

“I have a deep appreciation for technologically advanced organizations,” said Geoff.

Read the full article here

This content was provided by Avalere Health

Company Details

- PMLiVE

Avalere Health

Email
Website

 Latest Content from  Avalere Health 

Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs

Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.

Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient

As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.

Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities

As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.

Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies

Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.

Archetypes: Rethinking go-to-market expectations to drive commercial success

In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer

Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.

Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment

Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

The challenges of reimbursement and innovative pricing for cell and gene therapies

Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

Fishawack Health welcomes Mario Muredda as its new President of Marketing

Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.